CIK 0001177648 · Non-accelerated filer<br>Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 043205099
- Phone
- 617 607 0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-06 | FOLETTA MARK G Director | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | ||
| 2024-03-06 | CARTER BRUCE L A Director | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | ||
| 2024-02-26 | Gardiner Nathaniel S. Chief Legal Officer | Option exercise | +5,187 | $8.99 | $47K | 75,688 |
| 2024-02-26 | Gardiner Nathaniel S. Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −5,187 | 77,813 | ||
| 2024-02-12 | Luu Brendan Chief Business Officer | Grant or award | +3,320 | 40,056 | ||
| 2024-02-12 | Luu Brendan Chief Business Officer | Shares withheld for taxes | −973 | $12.41 | $12K | 39,083 |
| 2024-02-12 | Kieffer Tara Lynn Chief Product Strategy Officer | Grant or award | +3,320 | 40,580 | ||
| 2024-02-12 | Kieffer Tara Lynn Chief Product Strategy Officer | Shares withheld for taxes | −973 | $12.41 | $12K | 39,607 |
| 2024-02-12 | Gardiner Nathaniel S. Chief Legal Officer | Grant or award | +3,320 | 71,474 | ||
| 2024-02-12 | Gardiner Nathaniel S. Chief Legal Officer | Shares withheld for taxes | −973 | $12.41 | $12K | 70,501 |
| 2024-02-12 | Rottinghaus Scott T. Chief Medical Officer | Grant or award | +2,576 | 29,042 | ||
| 2024-02-12 | Rottinghaus Scott T. Chief Medical Officer | Shares withheld for taxes | −755 | $12.41 | $9K | 28,287 |
| 2024-02-12 | Or Yat Sun Chief Scientific Officer | Grant or award | +3,680 | 374,375 | ||
| 2024-02-12 | Or Yat Sun Chief Scientific Officer | Shares withheld for taxes | −1,080 | $12.41 | $13K | 373,295 |
| 2024-02-12 | MELLETT PAUL J Chief Fin. & Admin Officer | Grant or award | +3,320 | 96,869 | ||
| 2024-02-12 | MELLETT PAUL J Chief Fin. & Admin Officer | Shares withheld for taxes | −973 | $12.41 | $12K | 95,896 |
| 2024-02-12 | Luly Jay R. President and CEO | Grant or award | +5,400 | 812,193 | ||
| 2024-02-12 | Luly Jay R. President and CEO | Shares withheld for taxes | −1,584 | $12.41 | $20K | 810,609 |
| 2023-12-13 | Vance Terry Director | Sale | −15,295 | $9.12 | $139K | 5,800 |
| 2023-12-05 | Luu Brendan Sr. VP, Business Dev. | Sale | −2,125 | $9.63 | $20K | 36,736 |
Page 6 of 7 · 135 trades